BioSpace News Archive

Biotech Bay

Penumbra, Inc. to Present at Upcoming September 2023 Investor Conferences

Penumbra, Inc. announced that its management team is scheduled to present at the following investor conferences.

August 23, 2023
·
1 min read
Drug Development

Centessa Pharmaceuticals to Present Preclinical Data for Novel Orexin Receptor 2 (OX2R) Agonist at World Sleep Congress

Centessa Pharmaceuticals plc announced that preclinical data for ORX750, its first orexin agonist development candidate, will be featured in an oral presentation at the World Sleep Congress being held on October 20-25, 2023, in Rio de Janeiro, Brazil.

August 23, 2023
·
5 min read
Business

Evolus Announces Inducement Grants for New Chief Marketing Officer

Evolus, Inc. announced that the Compensation Committee of the Board of Directors approved the grant of stock options to purchase an aggregate of 83,555 shares of Evolus common stock and 63,358 restricted stock units to Tomoko Yamagishi-Dressler, the company’s new Chief Marketing Officer.

August 23, 2023
·
2 min read
Policy

Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System

Medtronic announced the outcome of the U.S. Food & Drug Administration Circulatory System Devices Panel meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation System.

August 23, 2023
·
4 min read
Biotech Bay

Nevro Announces Participation in Upcoming Investor Conferences - August 23, 2023

Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced today that it is participating in the following investor conferences.

August 23, 2023
·
2 min read
Deals

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic and wellness company, today announced that it has been completely vindicated in the securities class actions over the company’s 2018 initial public offering brought in the federal and state courts of New Jersey.

August 23, 2023
·
4 min read
Biotech Beach

Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data

Organovo Holdings, Inc. (Nasdaq: ONVO) (Organovo) today announced more details about its clinical program for FXR314, an FXR agonist that has completed initial clinical trials.

August 23, 2023
·
4 min read
Biotech Beach

Regulus Therapeutics to Host Virtual Investor Event on September 6, 2023

Regulus Therapeutics Inc today announced that it will host a virtual investor event on Wednesday, September 6, 2023.

August 23, 2023
·
5 min read
Biotech Beach

Cue Health to Present at Upcoming Investor Conferences

Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences.

August 23, 2023
·
1 min read
FDA

U.S. Food and Drug Administration Approves Orphan Drug Designation for NXC-201 as a Treatment for Multiple Myeloma

Nexcella, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) designation for NXC-201 for the treatment of a life-threatening form of blood cancer, multiple myeloma.

August 23, 2023
·
6 min read